Stellar Biotechnologies, Inc. (NASDAQ: SBOT) Starts Presentation at LD Micro Main Event
Stellar Biotechnologies (NASDAQ: SBOT) delivers sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient in many new immunotherapies (targeting cancer, immune disorders, Alzheimer's and inflammatory diseases) as well as a finished product for measuring immune status. Stellar is unique in its proprietary methods, facilities, and KLH technology. The company is committed to meeting the growing demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and developing KLH-based active immunotherapies. For more information, visit the company’s website at www.stellarbiotechnologies.com. About NetworkNewsWire…







